Henley Healthcare Subsidiary Files With FDA for Market Clearance.Business Editors & Health/Medical Writers SUGAR LAND, Texas--(BUSINESS WIRE)--Dec. 6, 2000 Henley Healthcare Inc. (Nasdaq:HENL) announced today that it's wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Enraf-Nonius B.V., based in the Netherlands, filed a 510(k) with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. to obtain market clearance for the Endomed 182. The Endomed 182 is a device for interferential current therapy with T.E.N.S. indications used for symptomatic relief symptomatic relief (sim·t  ·maˑ·tik r and management of
chronic pain and/or used as an adjunctive treatment for the management
of pain associated with post surgical and post-traumatic conditions.
As soon as the FDA grants market clearance, Enraf-Nonius will begin marketing the Endomed 182 in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Henley Healthcare Inc., develops, manufactures and distributes products and related accessories used in the control of acute or chronic pain. The company offers a diversified line of non-invasive physical medicine and rehabilitation physical medicine and rehabilitation or physiatry or physical therapy or rehabilitation medicine Medical specialty treating chronic disabilities through physical means to help patients return to a comfortable, productive life despite a medical products that are used in the treatment of disabilities or injuries with therapeutic exercise and the application of various heat, Fluidotherapy(R), traction, ultrasound or other modalities Modalities The factors and circumstances that cause a patient's symptoms to improve or worsen, including weather, time of day, effects of food, and similar factors. . Henley Healthcare is also awaiting FDA approval on its MicroLight microlight or microlite Noun a very small private aircraft with large wings microlight n → ultraligero microlight n 830(TM), a hand-held, low-energy (non-surgical) laser for the treatment of repetitive stress disorders such as carpal tunnel syndrome carpal tunnel syndrome: see repetitive stress injury. carpal tunnel syndrome (CTS) Painful condition caused by repetitive stress to the wrist over time. . For additional information on Henley Healthcare Inc. please visit the company's Web site at http://www.henleyhealthcare.com. Forward Looking Statements This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts, included in this press release that address activities, events or developments that the company expects, believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements are subject to certain risks, uncertainties and other factors, which could cause actual results to differ materially from those currently anticipated, including the risks and uncertainties set forth from time to time in Henley Healthcare's public reports and filings and other public statements. Readers are cautioned to consider these risks and uncertainties and not place undue reliance on these forward-looking statements. By making these forward-looking statements, Henley Healthcare undertakes no obligation to update these statements for revisions or changes after the date of this release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion